Scott Kopetz
- Oncology top 0.01%
- Colorectal Cancer Treatments and Studies 430
- Cancer Immunotherapy and Biomarkers 70
- Cancer Treatment and Pharmacology 62
- Hepatology top 0.1%
- Hepatocellular Carcinoma Treatment and Prognosis 67
- Cancer Research top 0.05%
- Cancer Genomics and Diagnostics 202
- Pathology and Forensic Medicine top 0.02%
- Genetic factors in colorectal cancer 221
- Pulmonary and Respiratory Medicine top 0.1%
- Lung Cancer Treatments and Mutations 102
- Gastric Cancer Management and Outcomes 59
- Co-authors
- Michael J. OvermanJean‐Nicolas VautheyDipen M. MaruCathy EngJayesh DesaiDavid G. MenterHeinz‐Josef LenzRobert A. Wolff
- Cited by
- OncologyHepatologyCancer Research
- Journals
- Journal of Clinical Oncology (247 papers)Annals of Oncology (44 papers)Cancer Research (32 papers)
- Partner nations
- United StatesItalySpain
In The Last Decade
Scott Kopetz
643 papers receiving 28.7k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Oncology 20.5k
- Hepatology 4.7k
- Cancer Research 7.6k
- Pathology and Forensic Medicine 7.6k
- Pulmonary and Respiratory Medicine 6.8k
Countries citing papers authored by Scott Kopetz
This map shows the geographic impact of Scott Kopetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Kopetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Kopetz more than expected).
Fields of papers citing papers by Scott Kopetz
This network shows the impact of papers produced by Scott Kopetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Kopetz. The network helps show where Scott Kopetz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Scott Kopetz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2022 | 20 | |
| 3 | 2022 | 37 | |
| 4 | 2021 | 8 | |
| 5 | Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Studybreakdown → | 2021 | 331 |
| 6 | 2020 | 19 | |
| 7 | 2018 | 33 | |
| 8 | 2017 | 196 | |
| 9 | 2017 | 47 | |
| 10 | 2017 | 201 | |
| 11 | 2017 | 38 | |
| 12 | 2015 | 59 | |
| 13 | Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF -Mutated Colorectal Cancerbreakdown → | 2015 | 513 |
| 14 | 2014 | 132 | |
| 15 | 2014 | 190 | |
| 16 | 2014 | 120 | |
| 17 | 2013 | 38 | |
| 18 | 2011 | 64 | |
| 19 | 2011 | 170 | |
| 20 | 2009 | 10 |
About Scott Kopetz
Scott Kopetz is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Hepatology and Pulmonary and Respiratory Medicine, having authored 676 papers that have together received 29.0k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (430 papers), Genetic factors in colorectal cancer (221 papers), Cancer Genomics and Diagnostics (202 papers), Lung Cancer Treatments and Mutations (102 papers), Cancer Immunotherapy and Biomarkers (70 papers), Hepatocellular Carcinoma Treatment and Prognosis (67 papers), Cancer Treatment and Pharmacology (62 papers) and Gastric Cancer Management and Outcomes (59 papers). The work is most often cited by research in Oncology (20.5k citations), Hepatology (4.7k citations), Cancer Research (7.6k citations), Pathology and Forensic Medicine (7.6k citations) and Pulmonary and Respiratory Medicine (6.8k citations). Scott Kopetz has collaborated with scholars based in United States, Italy and Spain. Frequent co-authors include Michael J. Overman, Jean‐Nicolas Vauthey, Dipen M. Maru, Cathy Eng, Jayesh Desai, David G. Menter, Heinz‐Josef Lenz, Robert A. Wolff, Christopher H. Lieu and Thierry André. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Clinical Cancer Research and Clinical Colorectal Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.